QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised)

NEW YORK, March 20 /PRNewswire/ -- QED International Associates Inc., administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares(TM) Exchange-Traded Funds, today announced the quarterly rebalancing of the Indexes. The following securities will be added and deleted in the Indexes effective before the opening of trading on NYSE Arca March 24, 2008.

Autoimmune-Inflammation Index (HHA)
Drop
GW Pharmaceuticals, Inc
Human Genome Sciences (NASDAQ:HGSI)
Ligand Pharmaceuticals, Inc. (NASDAQ:LGND)
Add
Fornix Biosciences N.V. (Amsterdam: FORBI.AS)
Meda AB (SHSE1: MEDA A)
Mitsubishi Tanabe Pharma Corporation

Cancer Index (HHK)
Drop
Shire PLC (NASDAQ:SHPGY)
Add
Ark Therapeutics Group Plc

Cardio Devices Index (HHE)
Drop
Biosphere Medical, Inc. (NASDAQ:BSMD)
Add
Zoll Medical Corp. (NASDAQ:ZOLL)

Cardiology Index (HRD)
Drop
Encysive Pharmaceuticals, Inc. (NASDAQ:ENCY)
Human Genome Sciences, Inc (NASDAQ:HGSI)
Vical, Inc. (NASDAQ:VICL)
Add
Mitsubishi Tanabe Pharma Corporation
Sangamo BioSciences Inc. (NASDAQ:SGMO)
Sciele Pharma, Inc. (NASDAQ:SCRX)

Composite Index (HHQ)
Drop
Advanced Medical Optics, Inc. (NYSE:EYE)
Align Technology Inc. (NASDAQ:ALGN)
Array Biopharma Inc. (NASDAQ:ARRY)
ArthroCare Corp. (NASDAQ:ARTC)
Endo Pharmaceuticals Hldgs. (NASDAQ:ENDP)
Fresenius Medical Care AG (XETRA: FME.DE)
GEDEON RICHTER RT (XETRA: R1G1.DE)
GENMAB A/S (Copenhagen: GEN.CO)
H LUNDBECK A/S (Copenhagen: LUN.CO)
Human Genome Sciences (NASDAQ:HGSI)
Imclone Systems (NASDAQ:IMCL)
Inverness Medical Innovations (AMEX:IMA)
Invitrogen Corp. (NASDAQ:IVGN)
Medarex Inc. (NASDAQ:MEDX)
Medicis Pharmaceutical (NYSE:MRX)
Mentor Corp. (NYSE:MNT)
ONYX Pharmaceuticals Inc. (NASDAQ:ONXX)
PDL BioPharma, Inc. (NASDAQ:PDLI)
Pharmion Corp. (NASDAQ:PHRM)
Progenics Pharmaceuticals Inc. (NASDAQ:PGNX)
Regeneron Pharmaceuticals (NASDAQ:REGN)
Respironics Inc. (NASDAQ:RESP)
Sepracor Inc. (NASDAQ:SEPR)
Theravance Inc. (NASDAQ:THRX)
United Therapeutics Corp. (NASDAQ:UTHR)
Valeant Pharmaceuticals Int'l (NYSE:VRX)
Vertex Pharmaceuticals (NASDAQ:VRTX)
Add
Adolor Corp. (NASDAQ:ADLR)
ALLOS THERAPEUTICS INC. (NASDAQ:ALTH)
Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY)
Alpharma Inc. (NYSE:ALO)
Altus Pharmaceuticals Inc. (NASDAQ:ALTU)
AMAG Pharmaceuticals Inc. (NASDAQ:AMAG)
ANGIOTECH PHARMACEUTICALS (NASDAQ:ANPI)
Ark Therapeutics
Bavarian Nordic A/S (Copenhagen: BAVA.CO)
Caraco Pharmaceutical Laboratories Ltd. (AMEX:CPD)
Cardiome Pharma Corp. (NASDAQ:CRME)
Coventry Health Care Inc. (NYSE:CVH)
CRUCELL-ADR (NASDAQ:CRXL)
CUBIST PHARMACEUTICALS INC. (NASDAQ:CBST)
Discovery Laboratories Inc. (NASDAQ:DSCO)
Eisai Co. Ltd.
Encysive Pharmaceuticals Inc. (NASDAQ:ENCY)
Enzo Biochem Inc. (NYSE:ENZ)
ENZON PHARMACEUTICALS INC. (NASDAQ:ENZN)
Exelixis Inc. (NASDAQ:EXEL)
Flamel Technologies (NASDAQ:FLML)
Illumina Inc. (NASDAQ:ILMN)
Incyte Corporation (NASDAQ:INCY)
Integra LifeSciences Holdings (NASDAQ:IART)
Meda AB (Stockholm: MEDAA.ST)
Mitsubishi Tanabe Pharma
Taisho Pharmaceutical Co., Ltd.

Dermatology and Wound Index (HRW)
Drop
Shire PLC (ADR) (NASDAQ:SHPGY)
SkyePharma Plc
Add
Standard Chemical & Pharm. Co., Ltd.
Taisho Pharmaceutical Co., Ltd.

Diagnostics Index (HHD)
Drop
CR Bard, Inc. (NYSE:BCR)
IDEXX Laboratories (NASDAQ:IDXX)
Add
Bruker Corporation (NASDAQ:BRKR)
Halozyme Therapeutic (NASDAQ:HALO)

Emerging Cancer Index (HHJ)
Drop
Adventrx Pharmaceuticals, Inc. (AMEX:ANX)
Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX)
Add
Dyanvax Technologies (NASDAQ:DVAX)
Synta Pharmaceuticals Corp. (NASDAQ:SNTA)

Enabling Technologies Index (HHV)
Drop
Hillenbrand Industries (NYSE:HB)
Add
Eurand N.V. (NASDAQ:EURX)

GI/Gender Index (HHU)
Drop
AEterna Zentaris (NASDAQ:AEZS)
King Pharmaceuticals (NYSE:KG)
Nastech Pharmaceutical (NASDAQ:NSTK)
Add
Columbia Laboratories Inc. (NASDAQ:CBRX)
Eisai Co. Ltd. (Tokyo Stock Exchange: 4523)
Mylan, Inc. (NYSE:MYL)

Metabolic-Endocrine Disorders Index (HHM)
Drop
Depomed Inc. (NASDAQ:DEPO)
Emisphere Technologies Inc. (NASDAQ:EMIS)
Flamel Technologies SA ADS (NASDAQ:FLML)
Hospira Inc. (NYSE:HSP)
Human Genome Sciences, Inc. (NASDAQ:HGSI)
Indevus Pharmaceuticals Inc. (NASDAQ:IDEV)
Ipsen Ltd. (Paris: IPN.PR)
Nektar Therapeutics (NASDAQ:NKTR)
NicOx S.A. (Paris: NCOX)
OSI Pharmaceuticals Inc. (NASDAQ:OSIP)
ProStrakan Group Plc
Solvay S.A. (Brussels: SVYSY)
Add
Altus Pharmaceuticals Inc. (NASDAQ:ALTU)
Amicus Therapeutics, Inc. (NASDAQ:FOLD)
Biodell Inc. (NASDAQ:BIOD)
CombinatoRx Inc. (NASDAQ:CRXX)
GW Pharmaceuticals Plc
Incyte Corp. (NASDAQ:INCY)
Orexigen Therapeutics, Inc. (NASDAQ:OREX)
Repros Therapeutics Inc. (NASDAQ:RPRX)
Sirtris Pharmaceuticals, Inc. (NASDAQ:SIRT)
SuperGen Inc. (NASDAQ:SUPG)
Transition Therapeutics Inc. (NASDAQ:TTHI)
XOMA Ltd. (NASDAQ:XOMA)

Neuroscience Index (HHN)
Drop
Neurochem Inc. (NASDAQ:NRMX)
Add
Caraco Pharmaceutical Laboratories Ltd. (AMEX:CPD)

Ophthalmology Index (HHZ)
Drop
Insite Vision Inc. (AMEX:ISV)
Add
King Pharmaceuticals (NYSE:KG)
Patient Care Services Index (HHB)
Drop
Fresenius Medical Care (XETRA: FME.DE)
Add
Coventry Health Care Inc. (NYSE:CVH)

The rebalanced Indexes, including the rebalanced Index Shares, are based on the closing prices as of March 14, 2008.

In accordance with the Exemptive Order, a complete list of the constituents reflecting the rebalancing will be posted at www.healthsharesinc.com/content/view/53/274/.

About QED International Associates

QED International, based in New York, is a leading financial industry consulting firm specializing in quantitative modeling and the design, development and maintenance of indexes and Exchange Traded Funds. For more information, visit the company's website at www.qedinternational.com

First Call Analyst:
FCMN Contact:

Source: QED International Associates Inc.,

CONTACT: Ed Matluck, CEO of QED International,
ematluck@edinternational.com; or Michael Carty, +1-212-953-4058, for QED
International

Web site: http://www.qedinternational.com/
http://www.healthsharesinc.com/content/view/53/274

2008-03-20 19:23:01 0317692 PRNEWSWIRE